Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Treanor

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Vaccine|October 3, 2017
Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cellsAdriana Forero, Katherine Fenstermacher, Nicholas Wohlgemuth, et al.
BMC Veterinary Research|January 8, 2021
Serological evidence for historical and present-day exposure of North American bison to Mycoplasma bovisKaren B Register, Margaret Parker, Kelly A Patyk, et al.
Journal of Virology|May 15, 2009
Simulation and prediction of the adaptive immune response to influenza A virus infectionHa Youn Lee, David J Topham, Sung Yong Park, et al.
Plos One|August 14, 2008
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaGregory E D Mullen, Ruth D Ellis, Kazutoyo Miura, et al.
Vaccine|July 8, 2008
Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccineH Keipp Talbot, Wendy Keitel, Thomas R Cate, et al.
The Journal of Pediatrics|February 5, 2004
Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infantsH Fred Clark, David I Bernstein, Penelope H Dennehy, et al.
Vaccine|June 25, 2011
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adultsRobert W Frenck, Robert Belshe, Rebecca C Brady, et al.
The Lancet. Microbe|May 10, 2024
Assessment of CD8<sup>+</sup> T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 studyThomas G Evans, Flora Castellino, Monika Kowalik Dobczyk, et al.
Clinical and Vaccine Immunology : CVI|December 28, 2013
Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trialSerge Durviaux, John Treanor, Jiri Beran, et al.
The New England Journal of Medicine|August 15, 2014
Efficacy of high-dose versus standard-dose influenza vaccine in older adultsCarlos A DiazGranados, Andrew J Dunning, Murray Kimmel, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Vaccine|October 3, 2017
Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cellsAdriana Forero, Katherine Fenstermacher, Nicholas Wohlgemuth, et al.
BMC Veterinary Research|January 8, 2021
Serological evidence for historical and present-day exposure of North American bison to Mycoplasma bovisKaren B Register, Margaret Parker, Kelly A Patyk, et al.
Journal of Virology|May 15, 2009
Simulation and prediction of the adaptive immune response to influenza A virus infectionHa Youn Lee, David J Topham, Sung Yong Park, et al.
Plos One|August 14, 2008
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaGregory E D Mullen, Ruth D Ellis, Kazutoyo Miura, et al.
Vaccine|July 8, 2008
Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccineH Keipp Talbot, Wendy Keitel, Thomas R Cate, et al.
The Journal of Pediatrics|February 5, 2004
Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infantsH Fred Clark, David I Bernstein, Penelope H Dennehy, et al.
Vaccine|June 25, 2011
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adultsRobert W Frenck, Robert Belshe, Rebecca C Brady, et al.
The Lancet. Microbe|May 10, 2024
Assessment of CD8<sup>+</sup> T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 studyThomas G Evans, Flora Castellino, Monika Kowalik Dobczyk, et al.
Clinical and Vaccine Immunology : CVI|December 28, 2013
Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trialSerge Durviaux, John Treanor, Jiri Beran, et al.
The New England Journal of Medicine|August 15, 2014
Efficacy of high-dose versus standard-dose influenza vaccine in older adultsCarlos A DiazGranados, Andrew J Dunning, Murray Kimmel, et al.
Pageof 6